Exact Mass: 430.2695044
Exact Mass Matches: 430.2695044
Found 500 metabolites which its exact mass value is equals to given mass value 430.2695044
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
4,4-Diapo-psi,psi-carotene-4-oic acid
Trandolapril
C24H34N2O5 (430.24675940000003)
C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Trandolapril
C24H34N2O5 (430.24675940000003)
Trandolapril is a non-sulhydryl prodrug that belongs to the angiotensin-converting enzyme (ACE) inhibitor class of medications. It is metabolized to its biologically active diacid form, trandolaprilat, in the liver. Trandolaprilat inhibits ACE, the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). Trandolapril may be used to treat mild to moderate hypertension, to improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction, as an adjunct treatment for congestive heart failure, and to slow the rate of progression of renal disease in hypertensive individuals with diabetes mellitus and microalbuminuria or overt nephropathy. C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
2-(2-Methylbutanoyl)-9-(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one
2-(2-Methylbutanoyl)-9-(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one is found in tea. 2-(2-Methylbutanoyl)-9-(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one is a constituent of Tussilago farfara (coltsfoot). Constituent of Tussilago farfara (coltsfoot). 2-(2-Methylbutanoyl)-9-(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one is found in tea.
Piritramide
Piritramide (R-3365, trade names Dipidolor, Piridolan, Pirium and others) is a synthetic opioid analgesic with a potency 0.65 to 0.75 times that of morphine. A common starting dose is 15 mg IV, equivalent to 10 mg of morphine hydrochloride. Piritramide is commonly used for the treatment of postoperative pain. Piritramide was discovered at Janssen Pharmaceutica in 1960 and is currently manufactured and distributed within continental Europe and some other places by Janssen-Cilag. Piritramide is a strong opioid and therefore is regulated much the same as morphine in all known jurisdictions. It was never introduced in the United States and is therefore a Schedule I/Narcotic controlled substance. It is listed under international treaties and other laws such as the German Betabungsmittelgesetz, the Austrian Suchtgiftmittelgesetz, the Opium Laws of various other European countries, Canadian controlled substances act, UK Misuse of Drugs Act of 1971, and equivalents elsewhere. Strangely enough, bezitramide, which is not currently marketed in the United States is a Schedule II/Narcotic controlled substance. Piritramide is also known as pirinitramide. Its closest chemical relatives amongst well-known drugs are diphenoxylate (Lomotil) and bezitramide (Burgodin). Piritramide is available in tablets and ampoules of sterile solution for injection by all routes, and is used in Patient Controlled Analgesia units. In addition to PCA, piritramide is most often used in post-operative situations and emergency departments; some of its properties would seem to lend it well to chronic pain control as well. It is one of the longer-lasting opioids and has a plasma half-life of 3 to 12 hours. Piritramide tends to cause less respiratory depression than morphine and can take a while to have full effect especially if taken by mouth. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics N - Nervous system > N02 - Analgesics > N02A - Opioids > N02AC - Diphenylpropylamine derivatives D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics
N-Eicosapentaenoyl Glutamine
N-eicosapentaenoyl glutamine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Eicosapentaenoic acid amide of Glutamine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Eicosapentaenoyl Glutamine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Eicosapentaenoyl Glutamine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
Urea, N'-(2,4-difluorophenyl)-N-((4-(2,2-dimethylpropyl)phenyl)methyl)-N-heptyl-
Indolapril
C24H34N2O5 (430.24675940000003)
Laurebiphenyl
A sesquiterpenoid that is a dimer of a cyclolaurane type sesquiterpene. Isolated from the marine red algae Laurencia nidifica and Laurencia tristicha, it exhibits antineoplastic activity.
Lupulone C
Lupulone C is a natural product found in Humulus lupulus with data available.
gutierrezianolic acid (2-methylbutyrate) methyl ester|gutierrezianolic acid <2-methylbutyrate> methyl ester
15alpha-Angeloyloxy-9beta-hydroxy-kaur-16-en-saeuremethylester|15alpha-angeloyloxy-stenolobin|ent-15beta-angeloxy-9alpha-hydroxykaur-16-en-19-oate|methyl 15alpha-angeloyloxy-9beta-hydroxy-ent-kaur-16-en-19-oate
12alpha-hydroxy-24-methyl-24,25-dioxoscalar-16-en-22-oic acid
9beta-hydroxy-15alpha-senecioyloxy-ent-kaurensaeure-methyl-ester
gutierrezianolic acid (isobutyrate) methyl ester|gutierrezianolic acid methyl ester
3beta-3,29-Dihydroxy-15-oxo-24,25,26-trinorlanosta-8,16-dien-23-oic acid
12alpha-(2-methylbutyryloxy)-hardwickiic acid methyl ester|12alpha-<2-methylbutyryloxy>-hardwickiic acid methyl ester
methyl-15beta-tiglinoyloxy-16,17-epoxy-ent-kaurane
methyl-3alpha-angeloyloxy-9beta-hydroxy-ent-kaurenoate
ent-7alpha-senecioxy-15alpha-hydroxy-atis-16-en-19-oic acid
rel-(1R,5R)-2-(1-farnesyl-5-acetoxy-2-oxocyclohex-3-en-1-yl)-acetic acid methyl ester
Val Ala Asn Lys
8-[2-(3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl)ethyl]-4a,7,8-trimethylspiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2-oxirane]-2,3-diol
C22H38O8_Spiro[naphthalene-1(2H),2-oxirane]-2,3-diol, octahydro-5,6,8a-trimethyl-5-[2-(tetrahydro-3,4-dihydroxy-2,5-dimethoxy-3-furanyl)ethyl]
8-[2-(3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl)ethyl]-4a,7,8-trimethylspiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2-oxirane]-2,3-diol
8-[2-(3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl)ethyl]-4a,7,8-trimethylspiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2-oxirane]-2,3-diol_37.6\\%
8-[2-(3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl)ethyl]-4a,7,8-trimethylspiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2-oxirane]-2,3-diol_major
8-[2-(3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl)ethyl]-4a,7,8-trimethylspiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2-oxirane]-2,3-diol_minor
8-[2-(3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl)ethyl]-4a,7,8-trimethylspiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2-oxirane]-2,3-diol_44.8\\%
Ala Gly Lys Arg
Ala Gly Arg Lys
Ala Lys Gly Arg
Ala Lys Asn Val
Ala Lys Arg Gly
Ala Lys Val Asn
Ala Asn Lys Val
Ala Asn Val Lys
Ala Arg Gly Lys
Ala Arg Lys Gly
Ala Val Lys Asn
Ala Val Asn Lys
Gly Ala Lys Arg
Gly Ala Arg Lys
Gly Ile Lys Asn
Gly Ile Asn Lys
Gly Lys Ala Arg
Gly Lys Ile Asn
Gly Lys Lys Val
Gly Lys Leu Asn
Gly Lys Asn Ile
Gly Lys Asn Leu
Gly Lys Gln Val
Gly Lys Arg Ala
Gly Lys Val Lys
Gly Lys Val Gln
Gly Leu Lys Asn
Gly Leu Asn Lys
Gly Asn Ile Lys
Gly Asn Lys Ile
Gly Asn Lys Leu
Gly Asn Leu Lys
Gly Gln Lys Val
Gly Gln Val Lys
Gly Arg Ala Lys
Gly Arg Lys Ala
Gly Val Lys Lys
Gly Val Lys Gln
Gly Val Gln Lys
Ile Gly Lys Asn
Ile Gly Asn Lys
Ile Ile Ser Val
Ile Ile Val Ser
Ile Lys Gly Asn
Ile Lys Asn Gly
Ile Leu Ser Val
Ile Leu Val Ser
Ile Asn Gly Lys
Ile Asn Lys Gly
Ile Ser Ile Val
Ile Ser Leu Val
Ile Ser Val Ile
Ile Ser Val Leu
Ile Thr Val Val
Ile Val Ile Ser
Ile Val Leu Ser
Ile Val Ser Ile
Ile Val Ser Leu
Ile Val Thr Val
Ile Val Val Thr
Lys Ala Gly Arg
Lys Ala Asn Val
Lys Ala Arg Gly
Lys Ala Val Asn
Lys Gly Ala Arg
Lys Gly Ile Asn
Lys Gly Lys Val
Lys Gly Leu Asn
Lys Gly Asn Ile
Lys Gly Asn Leu
Lys Gly Gln Val
Lys Gly Arg Ala
Lys Gly Val Lys
Lys Gly Val Gln
Lys Ile Gly Asn
Lys Ile Asn Gly
Lys Lys Gly Val
Lys Lys Val Gly
Lys Leu Gly Asn
Lys Leu Asn Gly
Lys Asn Ala Val
Lys Asn Gly Ile
Lys Asn Gly Leu
Lys Asn Ile Gly
Lys Asn Leu Gly
Lys Asn Val Ala
Lys Gln Gly Val
Lys Gln Val Gly
Lys Arg Ala Gly
Lys Arg Gly Ala
Lys Val Ala Asn
Lys Val Gly Lys
Lys Val Gly Gln
Lys Val Lys Gly
Lys Val Asn Ala
Lys Val Gln Gly
Leu Gly Lys Asn
Leu Gly Asn Lys
Leu Ile Ser Val
Leu Ile Val Ser
Leu Lys Gly Asn
Leu Lys Asn Gly
Leu Leu Ser Val
Leu Leu Val Ser
Leu Asn Gly Lys
Leu Asn Lys Gly
Leu Ser Ile Val
Leu Ser Leu Val
Leu Ser Val Ile
Leu Ser Val Leu
Leu Thr Val Val
Leu Val Ile Ser
Leu Val Leu Ser
Leu Val Ser Ile
Leu Val Ser Leu
Leu Val Thr Val
Leu Val Val Thr
Asn Ala Lys Val
Asn Ala Val Lys
Asn Gly Ile Lys
Asn Gly Lys Ile
Asn Gly Lys Leu
Asn Gly Leu Lys
Asn Ile Gly Lys
Asn Ile Lys Gly
Asn Lys Ala Val
Asn Lys Gly Ile
Asn Lys Gly Leu
Asn Lys Ile Gly
Asn Lys Leu Gly
Asn Lys Val Ala
Asn Leu Gly Lys
Asn Leu Lys Gly
Asn Val Ala Lys
Asn Val Lys Ala
Gln Gly Lys Val
Gln Gly Val Lys
Gln Lys Gly Val
Gln Lys Val Gly
Gln Val Gly Lys
Gln Val Lys Gly
Arg Ala Gly Lys
Arg Ala Lys Gly
Arg Gly Ala Lys
Arg Gly Lys Ala
Arg Lys Ala Gly
Arg Lys Gly Ala
Ser Ile Ile Val
Ser Ile Leu Val
Ser Ile Val Ile
Ser Ile Val Leu
Ser Leu Ile Val
Ser Leu Leu Val
Ser Leu Val Ile
Ser Leu Val Leu
Ser Val Ile Ile
Ser Val Ile Leu
Ser Val Leu Ile
Ser Val Leu Leu
Thr Ile Val Val
Thr Leu Val Val
Thr Val Ile Val
Thr Val Leu Val
Thr Val Val Ile
Thr Val Val Leu
Val Ala Lys Asn
Val Gly Lys Lys
Val Gly Lys Gln
Val Gly Gln Lys
Val Ile Ile Ser
Val Ile Leu Ser
Val Ile Ser Ile
Val Ile Ser Leu
Val Ile Thr Val
Val Ile Val Thr
Val Lys Ala Asn
Val Lys Gly Lys
Val Lys Gly Gln
Val Lys Lys Gly
Val Lys Asn Ala
Val Lys Gln Gly
Val Leu Ile Ser
Val Leu Leu Ser
Val Leu Ser Ile
Val Leu Ser Leu
Val Leu Thr Val
Val Leu Val Thr
Val Asn Ala Lys
Val Asn Lys Ala
Val Gln Gly Lys
Val Gln Lys Gly
Val Ser Ile Ile
Val Ser Ile Leu
Val Ser Leu Ile
Val Ser Leu Leu
Val Thr Ile Val
Val Thr Leu Val
Val Thr Val Ile
Val Thr Val Leu
Val Val Ile Thr
Val Val Leu Thr
Val Val Thr Ile
Val Val Thr Leu
isopropyl ester
15-keto Latanoprost
AL 6598
2-(2-Methylbutanoyl)-9-(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one
Piritramide
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics N - Nervous system > N02 - Analgesics > N02A - Opioids > N02AC - Diphenylpropylamine derivatives D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics
5-[2-(3,4-Dihydroxy-2,5-dimethoxytetrahydro-3-furanyl)ethyl]-5,6,8a-trimethyloctahydro-2H-spiro[naphthalene-1,2-oxirane]-2,3-diol
TRIETHYL 2,2,2-(1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIYL)TRIACETATE
4,8-Bis({[dimethyl(2-methyl-2-propanyl)silyl]oxy}methyl)-1,5-diazatricyclo[5.1.0.03,5]octane-2,6-diol
EHop-016
EHop-016 is a potent and selective Rac GTPase Rac1 and Rac3 inhibitor. EHop-016 inhibits Rac1 activity with an IC50 of 1.1 μM in MDA-MB-435 cells. EHop-016 inhibits Vav2 interaction with Rac, Rac-activated PAK1, lamellipodia formation, and cell migration[1][2].
TETRABUTYLPHOSPHONIUM TOLUENE-4-SULFONATE
C23H43O3PS (430.2670378000001)
4,4,5,5-tetramethyl-2-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)anthracen-2-yl]-1,3,2-dioxaborolane
1-[2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid
C24H34N2O5 (430.24675940000003)
Sodium Cholate
Digestion and Absorption of Fats: Bile acids are crucial for the digestion and absorption of dietary fats and fat-soluble vitamins (A, D, E, and K) in the small intestine. They achieve this by emulsifying large fat droplets into smaller droplets, increasing the surface area for action by lipase, an enzyme that breaks down fats. Cholesterol Metabolism: Bile acids are synthesized from cholesterol in the liver. They play a key role in cholesterol homeostasis by facilitating the excretion of cholesterol from the body. This process is important for regulating blood cholesterol levels. Bile Formation: Bile acids are a major component of bile, which is produced by the liver and stored in the gallbladder. Bile is released into the small intestine to aid in the digestion and absorption of fats. Hormone-like Functions: Bile acids can act as signaling molecules, influencing various metabolic processes through activation of nuclear receptors such as the farnesoid X receptor (FXR) and the G protein-coupled bile acid receptor 1 (GPBAR1, also known as TGR5). Lipid Solubility: Bile acids are amphipathic molecules, meaning they have both hydrophobic and hydrophilic regions. This property allows them to solubilize lipids and lipid-soluble substances, aiding in their transport and absorption. Microbial Metabolism: In the intestine, bile acids can influence the composition of the gut microbiota by affecting the growth of different bacterial species. The gut microbiota, in turn, can modify bile acids, influencing their function and the overall metabolic state of the host. D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
Diphenylacetylene-4,4-diboronic acid bis(pinacol) ester
Resocortol butyrate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
(2s,3s)-3-Amino-4-[(3s)-3-Fluoropyrrolidin-1-Yl]-N,N-Dimethyl-4-Oxo-2-(Trans-4-[1,2,4]triazolo[1,5-A]pyridin-5-Ylcyclohexyl)butanamide
C22H31FN6O2 (430.24923979999994)
(2E,4E,6E,8E,10E,12E,14E,16E,18E,20E,22E)-24-hydroxy-2,6,10,15,19,23-hexamethyltetracosa-2,4,6,8,10,12,14,16,18,20,22-undecaenal
5-[(E,5S,6S)-5,6-dihydroxy-6-[(2R,3R,5S)-5-[(2R,3S)-3-hydroxy-2-methylbutyl]-3-methyloxolan-2-yl]-3-methylhex-2-enoyl]oxypentanoic acid
asnovolin J
A meroterpenoid with formula C26H38O5 isolated from the fungus Aspergillus novofumigatus. It is an intermediate produced in the biosynthetic pathway leading to the synthesis of novofumigatonin.
methyl (1R,2S,5S,7R,10S,11S,13R,15R)-7-hydroxy-2,6,6,10,13,15-hexamethyl-17-methylidene-14,16-dioxotetracyclo[11.3.1.02,11.05,10]heptadecane-1-carboxylate
(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(3-pyridinylmethyl)amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(3-pyridinylmethyl)amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(3-pyridinylmethyl)amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
Gln-Lys-Arg
A tripeptide composed of L-glutamine, L-lysine, and L-arginine units joined in sequence by peptide linkages.
(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(3-pyridinylmethyl)amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(3-pyridinylmethyl)amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(3-pyridinylmethyl)amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(3-pyridinylmethyl)amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(3-pyridinylmethyl)amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(3-pyridinylmethyl)amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(3-pyridinylmethyl)amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(3-pyridinylmethyl)amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(3-pyridinylmethyl)amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(3-pyridinylmethyl)amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(3-pyridinylmethyl)amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(3-pyridinylmethyl)amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(3-pyridinylmethyl)amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
Andrastin E
A 17-oxo steroid that is andrastin D in which the keto group at position 3 has undergone formal reduction to give the corresponding 3alpha-hydroxy compound.
Andrastin F
A 17-oxo steroid that is andrastin D in which the keto group at position 3 has undergone formal reduction to give the corresponding 3beta-hydroxy compound.
methyl (3R)-3-[(2E,6E)-9-[(2R)-3,3-dimethyloxiran-2-yl]-3,7-dimethylnona-2,6-dienyl]-6-hydroxy-2,3,5-trimethyl-4-oxocyclohexa-1,5-diene-1-carboxylate
(2E,4E,6E,8E,10E,12E,14E,16E,18E,20E)-2,6,10,15,19,23-hexamethyltetracosa-2,4,6,8,10,12,14,16,18,20,22-undecaenoic acid
4,4-diapolycopen-4-oic acid
An apo carotenoid triterpenoid that is 4,4-diapolycopene in which one of the terminal methyl groups has been replaced by a carboxy group.
Cholic acid (sodium)
Cholic acid sodium is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Cholic acid sodium is orally active[1][2]. Cholic acid sodium is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Cholic acid sodium is orally active[1][2].
(1e,3s,3ar,5r,7s,7as)-1-ethylidene-7-isopropyl-3-[(2-methylbutanoyl)oxy]-4-methylidene-2-oxo-hexahydroinden-5-yl (2e)-3-methylpent-2-enoate
1-acetyl-3a,7-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl 2-methylbut-2-enoate
methyl (4ar,5s,6r,8as)-5-[2-(furan-3-yl)ethyl]-5,6-dimethyl-8a-{[(3-methylbutanoyl)oxy]methyl}-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylate
(8ar)-5-methyl-3-(pentadecyloxy)-1h,8h,8ah-3λ⁵-furo[3,4-e][1,3,2]dioxaphosphepine-3,6-dione
(1r,2s,11s,13s,14r,15s,18s,20r)-13,18-dihydroxy-1,7,11,15,19,19-hexamethyl-8,10-dioxapentacyclo[12.8.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]docosa-4(9),6-dien-5-one
(3r)-3-[(3as,5as,6s,7s,9as,11ar)-7-hydroxy-6-(hydroxymethyl)-3a,6,9a,11a-tetramethyl-3-oxo-4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]butanoic acid
(2r)-6-hydroxy-2-(2-hydroxypropan-2-yl)-5,5-bis(3-methylbut-2-en-1-yl)-7-(3-methylbutanoyl)-2,3-dihydro-1-benzofuran-4-one
5-(methoxycarbonyl)-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl 2,3-dimethyloxirane-2-carboxylate
(3r,8as)-5-propyl-3-(tridecyloxy)-1h,8h,8ah-3λ⁵-furo[3,4-e][1,3,2]dioxaphosphepine-3,6-dione
(1r,4s,5r,9s,10s,13r,15s)-5-(methoxycarbonyl)-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl (2s,3s)-2,3-dimethyloxirane-2-carboxylate
(1e)-2-[(1s,3r,5s,12r)-3-methoxy-3,11-dimethyl-11-(4-methylpent-3-en-1-yl)-2,6-dioxatricyclo[6.4.0.0¹,⁵]dodec-8-en-12-yl]ethenyl 3-methylbut-2-enoate
15-o-methyl-14-epi-neovibsanin f
{"Ingredient_id": "HBIN001710","Ingredient_name": "15-o-methyl-14-epi-neovibsanin f","Alias": "NA","Ingredient_formula": "C26H38O5","Ingredient_Smile": "CC(=CC(=O)OC=CC1C2=C(COC2CC(=O)C)C3CC1(CCC3C(C)(C)OC)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14392","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
15-o-methylneovibsanin f
{"Ingredient_id": "HBIN001713","Ingredient_name": "15-o-methylneovibsanin f","Alias": "NA","Ingredient_formula": "C26H38O5","Ingredient_Smile": "CC(=CC(=O)OC=CC1C2=C(COC2CC(=O)C)C3CC1(CCC3C(C)(C)OC)C)C","Ingredient_weight": "430.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14607","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11154655","DrugBank_id": "NA"}
2-o-methylneovibsanin h
{"Ingredient_id": "HBIN006255","Ingredient_name": "2-o-methylneovibsanin h","Alias": "NA","Ingredient_formula": "C26H38O5","Ingredient_Smile": "CC(=CCCC1(CC(C2=C(C1C=COC(=O)C=C(C)C)C(OC2)CC(=O)C)OC)C)C","Ingredient_weight": "430.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14608","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11750791","DrugBank_id": "NA"}
2-o-methylneovibsanin i
{"Ingredient_id": "HBIN006256","Ingredient_name": "2-o-methylneovibsanin i","Alias": "NA","Ingredient_formula": "C26H38O5","Ingredient_Smile": "CC(=CCCC1(CC(C2=C(C1C=COC(=O)C=C(C)C)C(OC2)CC(=O)C)OC)C)C","Ingredient_weight": "430.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14609","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11362444","DrugBank_id": "NA"}